Tirzepatide 45mg Peptide

Tirzepatide 45 mg is a high purity research peptide provided in a lyophilized form that can be used for scientific study and analysis. The chemical nature of Tirzepatide is classified as a dual GIP and GLP-1 receptor agonist, thus enabling scientists to study both incretins signaling pathways in a single molecule.
Each vial of Tirzepatide has 45mg of the substance, which gives an increased quantity research format of the product.

Tirzepatide 45mg – Dual Agonist Research Peptide

Tirzepatide is an acronym for LY3298176, which is a synthetic peptide that works as an agonist at both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.
As such, Tirzepatide will be of interest to researchers who study incretin receptor signaling and differences between single- and multiple-receptor peptide compounds.
The 45mg format will allow labs to use more material in their projects and experiments requiring a greater amount of compound from the same batch.

Why Choose Tirzepatide 45mg?

The 45mg vial provides a higher quantity of research material than the 20mg and 30mg formats. This can be useful for laboratories conducting longer experimental programmes or multiple analytical procedures involving material from a consistent production batch.
Selecting a larger research vial may also simplify sample management when the experimental protocol requires greater quantities of the same compound.
Vial size should always be selected according to the requirements and design of the individual laboratory investigation.

Understanding Dual GIP/GLP-1 Receptor Activity

Tirzepatide’s defining characteristic is its activity at two distinct incretin receptors.
The GIP receptor is involved in glucose-dependent insulinotropic polypeptide signalling and has become an important area of metabolic research.
The GLP-1 receptor represents another extensively studied incretin pathway and plays an important role in metabolic signalling research.
Combining activity at both receptors within one molecule enables scientists to investigate dual-receptor signalling and compare it with compounds designed primarily around a single receptor pathway.

99%+ Purity & Batch Testing

The quality and characterisation of research material are important considerations when designing reproducible laboratory experiments.
Tirzepatide 45mg is specified at 99%+ purity. Where available, a batch-specific Certificate of Analysis (COA) provides additional analytical information relating to the supplied material.
Researchers should review documentation associated with the individual batch and retain relevant batch numbers alongside experimental records to support traceability.